Press Releases

 Filter by Provider

Brighthouse Financial, Inc. (“Brighthouse Financial” or the “company”) (Nasdaq: BHF) announced today that on December 26, 2025, holders of record as of December 10, 2025 (the “Record Date”) of (i) its depositary shares (the “Series A Depositary Shares” (Nasdaq: BHFAP)), each representing a 1/1,000th interest in a share of its 6.600% Non-Cumulative Preferred Stock, Series A (the “Series A Preferred Stock”), (ii) its depositary shares (the “Series B Depositary Shares” (Nasdaq: BHFAO)), each representing a 1/1,000th interest in a share of its 6.750% Non-Cumulative Preferred Stock, Series B (the “Series B Preferred Stock”), (iii) its depositary shares (the “Series C Depositary Shares” (Nasdaq: BHFAN)), each representing a 1/1,000th interest in a share of its 5.375% Non-Cumulative Preferred Stock, Series C (the “Series C Preferred Stock”) and (iv) its depositary shares (the “Series D Depositary Shares” (Nasdaq: BHFAM)), each representing a 1/1,000th interest in a share of its 4.625% Non-Cumulative Preferred Stock, Series D (the “Series D Preferred Stock”), will receive the following quarterly distributions, as applicable:

Scribe Therapeutics Inc. (“Scribe”), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care treatments for prevalent diseases, presented breakthrough preclinical data across its cardiometabolic pipeline (STX-1150 for LDL-C lowering, STX-1200 for Lp(a) lowering, and STX-1400 for triglyceride lowering) at the American Heart Association (AHA) Scientific Sessions 2025.

OncoNano Medicine, Inc. (“OncoNano”) announces the appointment of Brent Sorrells as Chief Operating Officer. Bringing more than two decades of experience in product development, strategic operations and commercial execution across the biotechnology industry, Mr. Sorrells will help drive OncoNano’s next phase of growth and operational excellence.

Wolfspeed, Inc., a global leader in silicon carbide technology, today announced its new 1200V SiC six-pack power modules that redefine performance benchmarks for high-power inverters. By combining its latest advanced Gen 4 SiC MOSFET technology and innovative packaging, Wolfspeed’s modules deliver three times more power cycling capability at operating temperature than competing solutions, and 15% higher inverter current capability in an industry-standard footprint.

Profluent Bio announced a research collaboration with the Rett Syndrome Research Trust (RSRT) to design novel base editors to permanently correct inherited mutations that lead to Rett syndrome, a rare neurodevelopmental disorder. The partnership centers on families living with Rett every day and is grounded in a shared commitment to move the therapeutic science forward with urgency, rigor, and transparency.

Kōloa Landing Resort at Po‘ipū is turning up the aloha spirit this holiday season with two deals that combine luxury travel and unforgettable island flavor. From 12:01 a.m. on Black Friday, Nov. 28, through midnight on Cyber Monday, Dec. 1, 2025 (HST), travelers and food lovers can take advantage of limited time offers on resort stays and Kaua‘i Poke Fest 2026 tickets.

Verifast, the AI-powered Verification-as-a-Service platform that automates financial analysis and decision-making for resident screening, mortgage underwriting, and other verticals, today announces the promotions of Becca Stafford to Chief Operating Officer and Jessica Tierney to Chief Integration Officer. These executives bring deep expertise, and innovation to the Verifast C-suite as the company scales to meet growing demand and momentum.

Stellar Cyber, the cybersecurity illumination company, today announced it has been recognized as a Representative Vendor in the Gartner Hype Cycle for Midsize Enterprises, 2025 (ID G00833100), within the Extended Detection and Response (XDR) category.

Supercomputing 2025 — Hammerspace, the high-performance data platform for AI Anywhere, today announced the upcoming release of Hammerspace v5.2, delivering performance, security and ecosystem enhancements that help organizations unify, automate and accelerate their AI and high-performance workloads across any on-premises, hybrid or cloud-based infrastructure.

Almonty Industries Inc. (“Almonty” or the “Company“) (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, is pleased to announce that it has commenced operations in the United States with the successful acquisition of a 100% ownership of the Gentung Browns Lake Tungsten Project in Beaverhead County, Montana. With this closing, Almonty has added one of the most advanced undeveloped tungsten assets in the United States to its global portfolio.

KB Home (NYSE: KBH), one of the largest and most trusted homebuilders in the U.S., today announced the grand opening of Chapel Manor, a new-home community in Zephyrhills, Florida. These new homes are designed for the way people live today, with popular features like modern kitchens overlooking large great rooms, expansive bedroom suites with walk-in closets, and lofts. The community’s one- and two-story floor plans feature up to six bedrooms and three-and-a-half baths. Chapel Manor is zoned for Pasco County Schools, with New River Elementary, Centennial Middle and Zephyrhills High Schools all within three miles of the community. Additionally, Chapel Manor has no CDD fees.

BDO’s second annual Audit Innovation Survey, released today, finds that the use of advanced technologies in the audit has crossed from cautiously experimental to increasingly mature. The research also finds that as tech adoption increases, the role of the auditor in providing judgment, professional skepticism, and the ability to interpret complex data is becoming more critical than ever before.

A coalition of leading marketing, communications and industry organizations serving the public sector today announced the launch of The Echo Awards, a new program recognizing journalists whose work amplifies understanding of government, policy, and the business of the public sector.

ECI Software Solutions, a leader in AI-powered, cloud-based business management software and services, today announced its NET1 Commerce Suite for North American manufacturers. The modern self-service portal is designed to automate and simplify critical financial processes, improve cash flow predictability, and provide real-time visibility into financial activity

The Cannata Report, a leading intelligence resource for the imaging, business technology and managed print services industry, presents its 2025 Frank Award for Best Male Executive to Toshiba America Business Solutions President and Chief Executive Officer Larry White.

AV Laboratories is bringing biotechnology out of the research lab and into the realm of daily skincare. Founded by a team of scientists and innovators with deep roots in IVF and stem cell research, AV Laboratories is pioneering a new frontier in molecular skin longevity with its patented AVL SOM3® complex — a formulation that delivers precise cellular nutrition to help skin renew, restore, and rejuvenate from within.

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 18th, at 11:30 a.m. GMT (6:30 a.m. ET). Management will provide an overview of Charles River’s strategic focus, business developments, and recent trends.

Nomi Health today announced a strategic partnership with Henry Ford Health, one of the Midwest’s largest and most trusted health systems, to eliminate out-of-pocket healthcare costs for consumers while lowering costs for employers. The partnership marks a significant expansion of the direct contracting model.

TrueBlue (NYSE: TBI), a leading provider of specialized workforce solutions, today announced that its PeopleReady brand’s JobStack staffing app has been recognized as a triple “Best of Category” winner in the 2025 Globee® Awards for Technology, Innovation, and Business, including being recognized as Business Product of the Year. These honors highlight JobStack’s role in transforming staffing through technology—helping businesses fill jobs faster while giving workers greater access to flexible opportunities.

ON24 (NYSE: ONTF), the leading customer engagement platform for B2B sales and marketing, today announced the issuance of U.S. Patent No. 12,445,698 B2, which protects ON24’s artificial intelligence technology that automatically identifies and extracts “Key Moments” from long-form video content, including virtual and digital events. These distilled highlights, or “Key Moments,” can be seamlessly deployed by ON24 customers across personalized nurture campaigns, shared on social media platforms, or delivered to specific audience segments to increase audience engagement with their campaigns.

SiteOne® Landscape Supply, Inc. (NYSE: SITE) announced today its acquisition of CC Landscaping Warehouse Plus, a wholesale distributor of nursery products, bulk materials and landscape supplies in Bradenton, Florida.

The world’s largest independent staking provider Figment with $18 billion in assets under stake is expanding into stablecoin yield products with OpenTrade, with leading custodial support from Crypto.com. The first product, OpenTrade Stablecoin Staking Yield Powered by Figment, delivers an average 15% APR on stablecoins (based on historical data and subject to market conditions). It is a first-of-its-kind combination of staking rewards and hedging against the underlying price volatility of staked tokens. The product is powered by a dedicated Figment-run validator combined with OpenTrade’s institution-grade stablecoin yield infrastructure. Crypto.com will serve as the custodian of the staked assets and exchange for transactions.

Valley National Bancorp (NASDAQ: VLY), the holding company for Valley National Bank, announced today the appointment of Curt Lang as the Chief Banking Officer for New Jersey. In this role, Lang will lead the strategic direction and drive the growth of Valley’s commercial banking portfolio across the state.

Zero Networks, a leading provider of zero trust security solutions, today congratulates Hans Vermeulen (CISSP, CCSP, CCSK, CISA, SCF), Architect, Platform Security at Vodafone Group, for being selected as the grand prize winner of the 2025 Containment Island competition. By participating in a 4-week event series of practical webinars and weekly challenges, not only has Vermeulen gained Continuing Professional Education (CPE) credits and practical skills for network segmentation, zero trust and stopping lateral movement, but they have also earned an all expenses paid trip to the Bahamas.

Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has raised $120 million in an oversubscribed and upsized financing to accelerate the development of its clinical pipeline and proprietary CloakLink™ linker platform.

Integrated Data Services (IDS), part of the Arlington Capital Partners portfolio, announces the release of Comprehensive Cost and Requirement (CCaR™) v2025.4.0, marking a major milestone in mission-driven decision support. The newest version introduces the CCaR™ Prioritization Tool, designed to help leaders cut through complexity and make confident, transparent funding decisions that drive measurable impact.

Hummink is redefining how the world’s smallest technologies are made, using ultra-precise printing to fix microscopic flaws and power the next generation of chips and displays.

GBHI to invest in high yield corporate bonds, investment-grade, hybrid or equity-related securities

STMicroelectronics announces status of common share repurchase program

Amsterdam – HERE Technologies, the leading mapping and technology company, announced the automotive industry’s first data-driven Software-Defined Vehicle (SDV) Maturity Framework, developed through independent research by technology advisory firm Omdia. As automakers struggle with fragmented SDV development approaches that are driving costly missteps and threatening business viability, this framework provides the industry's first common language for assessing progress and making strategic decisions in the rapidly evolving SDV landscape. 

 November 17, 2025Innovation uses AI to track and visualize tiny repair devices* through the beating heart, helping clinicians navigate in 3D with enhanced clarity and confidence**Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced DeviceGuide, an AI-powered device tracking* solution that assists physicians during one of interventional cardiology’s most technically demanding procedures: repairing leaking heart valves through a minimally invasive approach. Built on Philips’ EchoNavigator platform, this software brings AI directly into the procedure room, translating complex imaging into intuitive, real-time visual guidance that helps clinicians navigate the beating heart with greater clarity and confidence. It will be previewed at London Valves 2025 (November 16-18), one of the world’s leading meetings for structural heart specialists.“With DeviceGuide, we’re bringing AI into the heart of the procedure room, and into the heart itself,” said Dr. Atul Gupta, Chief Medical Officer, Diagnosis & Treatment at Philips. “This is Philips’ first AI assisting physicians in real time to visualize and guide heart valve treatment devices* as they navigate the beating heart. It’s helping doctors in the moment as they are helping their patients with structural heart disease.”Minimally invasive treatment of the mitral valveA leaking heart valve, known as mitral valve regurgitation, is a condition in which blood leaks backward through the heart’s mitral valve. It affects more than 35 million [1] adults worldwide, leaving many short of breath, fatigued, and struggling with everyday activities like climbing stairs or walking short distances. Many also live with anxiety or fear, knowing their heart isn’t pumping efficiently. If left untreated, severe cases can lead to heart failure and other serious complications.For patients who are too frail for open-heart surgery, minimally invasive transcatheter repair techniques such as mitral transcatheter edge-to-edge repair (M-TEER) offer a vital treatment option. During these procedures, physicians repair a leaking valve through a tiny incision in the top of the leg in the groin area, guiding long, flexible instruments through the blood veins and navigating a miniature repair device into the beating heart.Clinicians must view and interpret both X-ray and ultrasound images on multiple screens, coordinate movements between two operators, and make precise adjustments to grasp the moving valve leaflets, position the repair device, and confirm the result in real time. The process demands accuracy, coordination, and experience from the team. This is where DeviceGuide can help with its 3D navigation support.How AI is helpingDeviceGuide uses an AI algorithm to automatically track the tiny repair device as it moves through the beating heart, intelligently combining live echo and X-ray images. It creates a virtual 3D model of the treatment device in real time, superimposed on the live images of the beating heart. This allows clinicians to see where the device is and in which direction it is pointing, providing a clear view of the procedure and potentially enabling them to navigate the device more easily to effectively seal the leak.“The AI software serves as an assistive tool, with the physician always remaining in control. This isn’t about replacing expertise – it’s about amplifying it,” added Dr. Atul Gupta. “By embedding AI into the procedure, DeviceGuide gives physicians an extra pair of eyes, effectively bionic vision, helping them treat more patients safely and confidently.”Collaboration with Edwards LifesciencesThis innovation was developed in close collaboration with Edwards Lifesciences, the manufacturer of these repair devices. The solution combines Philips’ expertise in medical imaging and AI technologies with Edwards’ global leadership in structural heart innovation. Together, the companies have reimagined key parts of the mitral TEER procedural workflow.“DeviceGuide demonstrates the impact of combining leading imaging and therapy expertise to develop solutions designed around the procedural workflow, a model that will shape the future of AI-enabled image-guided structural interventions,” said Mark Stoffels, Business Leader, Image Guided Therapy Systems.This solution illustrates how Philips’ imaging and AI expertise can merge with the insights of leading therapy companies to innovate procedural workflows. This kind of collaboration is a model for developing the next generation of AI-enabled, image-guided innovations, centered on the needs of clinicians and their patients.Read more on how Philips DeviceGuide works here.

Comprehensive Framework Developed by Ed.D. Credentialed Educators and HR Experts Sets New Benchmark for Education Workforce Quality

Agreement Positions Datavault as a Leader in Valuation, Digitization, and Monetization of Real-World Assets (RWA)

NEWTON, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced that the first participant has been dosed in the open-label extension (OLE) portion of its Phase 2 ALTITUDE-AD clinical trial evaluating sabirnetug (ACU193) in people with early Alzheimer's disease.

WESTLAKE VILLAGE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the FDA acceptance of a supplemental New Drug Application (sNDA) for ZORYVE® (roflumilast) cream 0.3%, a once-daily, advanced targeted topical phosphodiesterase-4 (PDE4) inhibitor, to expand the indication for the topical treatment of plaque psoriasis to include children 2 to 5 years old. The FDA has set a PDUFA target action date of June 29, 2026, for this application.

Approval marks continued progress in expanding reimbursement pathways and accelerating access to advanced personal exoskeleton technology for individuals with spinal cord injury.

ZEELAND, Mich., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX) announced today that it has acquired Toronto-based BioConnect, a leader in biometric authentication solutions. The company provides a market-leading, multi-modal authentication software platform for the security and access control industry.

BELTSVILLE, Md., Nov. 17, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, today announced the closing of its previously announced private placement in public equity (“PIPE”). The PIPE was led by Ikarian Capital, Squadron Capital Management, Affinity Healthcare Fund, LP, and Exome Asset Management, with participation from other healthcare focused funds, for total gross proceeds of approximately $21.5 million.

Two-day event will outline Mavenir’s strategy and roadmap across Core and AI-enabled automation, supporting operators on the journey from AI-integrated to AI-native networks

TORONTO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Celestica Inc. (NYSE: CLS) (TSX: CLS), a global leader in data center infrastructure and advanced technology solutions, today introduced its latest storage platform, the SD6300 ultra-dense storage expansion (JBOD) system to help address the data growth challenges of AI environments, traditional enterprise and hyperscale data centers.

Export growth and margin improvement drive continued performance

EMERYVILLE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today announced that Jian Irish, Ph.D., M.B.A, President and Chief Executive Officer of Metagenomi, will be presenting at the Jefferies Global Healthcare Conference in London on Thursday, November 20, 2025, at 9:30 a.m. GMT.

DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, today announced that Chief Executive Officer Eric Remer and SVP, Finance, & Head of Investor Relations Brad Korch will present and participate in 1x1 meetings at the 2025 RBC Capital Markets Global Technology, Internet, and Media & Telecommunications Conference in New York on Tuesday, November 18, 2025. The presentation is at 3:20 p.m. EST.

SINGAPORE, Nov. 17, 2025 (GLOBE NEWSWIRE) -- SAIHEAT Limited (“SAIHEAT” or the “Company”) (NASDAQ: SAIH), is pleased to announce that it has secured the patent for “Waste Heat Recovery System and Method”.

$400 million from the Canada Enterprise Emergency Funding Corporation (CEEFC) and $100 million from the Province of Ontario strengthening Algoma’s balance sheet as the Company advances its EAF transition

ST. LOUIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Curium, a company dedicated to using cutting edge technology and innovative science in nuclear medicine to diagnose and treat millions of patients with cancer, announced today it is evolving into a new phase of discovery to revolutionize cancer treatment for patients. To accelerate biopharma innovation, Curium has set up their global headquarters in Boston, Massachusetts and has launched a new Business Unit, Curium Biopharma, to lead discovery and new product development. Curium is also expanding manufacturing capacity in Maryland Heights, Missouri and Noblesville, Indiana. Onshoring the manufacturing of our new therapeutic and diagnostic products is critical to reliably serving our customers and patients throughout North America.

State-of-the-art clean rooms enable accelerated development of microwave products

SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, is pleased to invite investors to a webinar on November 19, 2025, at 1:15 p.m. PT.

BOSTON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today announced participation in a panel discussion at the TD Cowen Treatment Advancements in Obesity and Related Disorders Summit taking place virtually on November 24, 2025.

Buntanetap significantly improves cognition in all Parkinson’s patients, with those exhibiting Alzheimer’s co-pathology showing a three-times greater response